(EMAILWIRE.COM, January 17, 2019 ) The global gastrointestinal stent market is projected to reach USD 452.6 Million by 2022 from USD 353.4 Million in 2017, at a CAGR of 5.1% during the forecast period. Market growth can be attributed to the growth in the geriatric population, increasing preference for minimally invasive surgeries, rising prevalence of GI cancers and other digestive diseases, and changing lifestyles.

The report analyzes the global gastrointestinal stent market, by product, material, disease type, end user, and region. Based on product, the biliary stents segment accounted for the largest share of global market in 2016. This can be attributed to the high prevalence of pancreatic cancer and biliary diseases as well as the growth in the number of surgical procedures for the treatment of these diseases.

Free Sample Report - https://www.marketsandmarkets.com/requestsampleNew.asp?id=167758126

Based on material, the self-expanding metal stents segment accounted for the largest share of the global gastrointestinal stent market in 2016. The large share of this segment can be attributed to their ease of insertion, a lower possibility of dislodgment or migration, its longer patency because of the large luminal diameters, high longevity, and large use of it in interventional endoscopy for various malignant obstructions.

On the basis of disease type, the biliary diseases segment accounted for the largest share of the global gastrointestinal stent market in 2016. The large share of this segment is attributed to the high prevalence of gastrointestinal diseases in the elderly population.

Download Free PDF - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=167758126

The global gastrointestinal stent market, by end user, is segmented into hospitals and ambulatory surgery centers. In 2016, the hospitals segment accounted for the largest share of the market. The large share of this segment can be attributed to the large number of endoscopic procedures performed in hospitals for various gastrointestinal diseases.

Market Players
Prominent players in the global gastrointestinal stent market are Boston Scientific (US), Cook Group (US), C.R. Bard (US), ELLA-CS (Czech Republic), Becton, Dickinson and Company (US), Merit Medical Systems (US), CONMED (US), Cantel Medical (US), Olympus (Japan), Taewoong Medical (South Korea), Micro-Tech (Nanjing) (China), Endo-Flex (Germany), and M.I. Tech (South Korea).